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Abstract

Xanthogranulomatous pyelonephritis (XGP) is characterized by the presence of lipidladen foamy macrophages with both acute and chronic phase inflammatory cells. The
aim of the study is to present our experience about patients with Xanthogranulomatous
pyelonephritis. 29 patients were evaluated through a complete anamnesis and the
preoperative management included routine blood and biochemical tests, urine culture and
renal ultrasound, intravenous urography and computed tomography (CT). All patients
underwent open nephrectomy followed by the pathological exam. The main symptoms of
these patients were fever and flank pain. Preoperative laboratory tests revealed anemia,
leukocytosis and increasing levels of blood urea nitrogen (BUN) and creatinine. Kidney
failure was noticed in almost half of the cases. This study succeeded to evaluate the
demographic, clinical, biological, surgical and histological characteristics. A
pathological diagnosis is mandatory mainly for the evaluation of its coexistence with
renal carcinoma.
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Highlights

 Xanthogranulomatous pyelonephritis (XGP) occurs due to recurrent chronic infection
secondary to renal lithiasis and it is frequently underdiagnosed due to its unspecific
symptoms which mimic other conditions.

Xanthogranulomatous pyelonephritis, urinary tract infection, E. Coli, anemia,
leukocytosis, nephrectomy

 CT is considered the imaging technique of choice in the diagnosis of the disease
preoperatively and a plethora of CT characteristics have been described so far.
 A diagnosis of certainty is mandatory to be pathological, which is useful not only in the
confirmation of the disease, but also in the evaluation of its coexistence with renal
carcinoma.
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Introduction
Xanthogranulomatous pyelonephritis (XGP) is a
chronic inflammation of the renal parenchyma, which was
first described in 1916 by Schlagenhaufer and it occurs in
approximately 1% of all renal infections. Two major
forms can be recognized: diffuse and focal (1). Some
authors also describe the segmental xanthogranulomatous
pyelonephritis which involves only a segment of the
kidney. The diffuse form can be easily confused with a
severe abscess or pyonephrosis, while the focal form is
called pseudotumoral because it is usually confused with
a renal tumor.
It generally occurs due to recurrent chronic infection
secondary to renal lithiasis which usually leads to
obstruction. The infection is usually associated with
Proteus or E. Coli, but Pseudomonas is also frequently
involved (2). Other agents identified are Staphylococcus
aureus, Candida, Bacteroides, group B Streptococcus or
Klebsiella. Although nephrolithiasis is usually present, it
is not mandatory for diagnosis. The xanthogranulomatous
pyelonephritis behaves like a pseudo tumor capable of
local invasion and destruction, starting with the kidney,
continuing with perinephric fat and, if left untreated,
involving the adjacent retroperitoneal structures (3, 4).
Histologically, the condition is characterized by the
presence of lipid-laden foamy macrophages with both
acute and chronic phase inflammatory cells. Focal
abscesses may be present.
In most cases, men are affected less than women, with
a female to men ratio of 5:1 (5). Regarding the
preoperative diagnosis, XGP is frequently underdiagnosed
due to its unspecific symptoms which mimic other
conditions such as perinephric abscess, pyelonephritis or
renal tuberculosis. There is no single clinical or radiologic
element of diagnosis specific to xanthogranulomatous
pyelonephritis (6). Symptoms include fever, flank pain,
lower urinary tract symptoms, hematuria or weight loss.
30% of patients presented complications such as
paranephric abscess, nephrocolonic or nephrocutaneous
fistula (7).
Usually, the transabdominal ultrasound evaluation is
used to assess the disease. Signs such as hydronephrosis,
less parenchymal tissue, staghorn calculus, often indicate
a diffuse form, while there are no specific lesions for a
focal form. CT findings are strong indicators that reveal
helpful information about local and regional involvement.
Nowadays, CT is considered the chosen imaging
procedure for the preoperative diagnosis of the disease,
numerous CT characteristics having been described so far.
The most typical CT features of XGP should be
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considered: low-density fluid-filled areas within the renal
parenchyma and additional elements indicating
perinephric extension. Studies describe the MRI
evaluation as a sensitive method in identifying lipid-laden
foamy macrophages (6).
The treatment for the diffuse form of the disease is
usually nephrectomy. For the focal form, patients who
have contraindications for surgery or bilateral form of the
disease, antibiotics are the key to the treatment if there is
any diagnosis based on biopsy or combined cytological
and clinical features (8). The prognosis is considered
reasonable
after
the
treatment.
Death
from
Xantogranulomatous pyelonephritis is exceedingly rare,
although morbidity is substantial. Transitional cell
carcinoma located in the renal pelvis has been associated
with the disease.
The goal of the study is to present our experience with
patients diagnosed with XGP in our clinic and to evaluate
the demographic, clinical, paraclinical, surgical and
histological characteristics of this series of patients, for a
better understanding and knowledge of the disease.

Materials and Methods
We conducted a retrospective observational study
from January 2013 to December 2017 that identified 29
patients diagnosed with XGP histologically confirmed
who have been treated in our clinic (9). Moreover,
patients with Xanthogranulomatous pyelonephritis
associated with renal carcinoma have also been included.
All patients were evaluated through a complete
anamnestic and a rigorous physical exam. Preoperative
management included routine blood tests and biochemical
urine tests, summary and urinalysis (10). Also, all patients
underwent renal ultrasound, intravenous urography and
computerized tomography – Figure 1. Patients with low
excretory functions at the intravenous urography
underwent renal scintigraphy with Tc99m-DTPA to
confirm the non-functioning kidney and to evaluate the
function of the other kidney. Any urinary tract infection
was treated with antibiotics before the surgical
intervention, or depending on the severity of the case, the
patients underwent percutaneous nephrostomy or Cook
stent (double JJ stent) insertion.
The parameters considered were: age, sex, complete
blood tests, urine tests, symptoms at presentation such as
fever and pain location, affected sides, surgical method
and pathological exam. All collected data were analyzed
and interpreted using Microsoft Word 2013 and Microsoft
Excel 2013. Simple descriptive statistics were calculated
(11-13).

Xanthogranulomatous pyelonephritis

Results and Discussions
The statistical analysis of our database comprising 29
patients treated in our hospital revealed that there were 25
women (86.2%) and only 4 men (13.8%), with a female to
male ratio of 6.1:1, with a mean age of 54.93 years –
Table 1. More than a half (51.72%) were aged between 40
and 60, over one third (37.93%) between 60 and 80 and
only 10.34% were aged under 40, similar results being
reported in a study performed in Argentina (14).
Table 1. Patients Characteristics
Mean Age
Sex
Symptoms

M
F
Fever
Flank
Pain

Yes
No
Yes
No

Associated
lithiasis

Yes

54.95 years
%
no
13.79% 4
86.2%
25
55.17% 16
44.82% 13
89.65% 26
10.34%
72.41%

3
21

No
27.58% 8
Left
44.82% 13
Right
55.17% 16
Urine culture
Positive
62.06% 18
Negative
37.93% 11
As many authors consider, the main symptoms are
flank pain and fever. In our study, unilateral flank pain
was the main presentation symptom (89.65%) followed
by fever (55.17%). In more than a half (51.72%) of the
patients, flank pain and fever coexisted at first
presentation. Close values are found in related studies (2).
The pain of XGP is not colicky in nature; it is usually dull
and persistent (15).
In the following chart, we noted that the main
symptom for which patients were admitted to our hospital
was a combination of fever and flank pain in 15 cases,
flank pain in only 11 cases, two of them being
asymptomatic and one presenting fever only – Figure 3.
Affected side

Figure 1. CT pelvic scans in a patient with
xathogranulomatous pyelonephritis highlighting
the invasion of the disease
All patients underwent nephrectomy, followed by the
pathological exam in order to confirm the diagnosis. The
tissue samples were placed in formaldehyde and then
hematoxylin eosin stain was used for microscopical
observations. The diagnosis of XGP was made due to the
presence of diffuse or focal inflammatory processes with
lipid-laden macrophages and chronic granulomatous
inflammation – Figure 2. Postoperatively, the lab tests
were repeated and the patients were carefully monitored.

Figure 2. The pathological examination of XGP
made from inflammatory lymphoplasmocitary
infiltrate and abundant xantomate cell, HE stain

Figure 3. Column chart representing the
patients’ symptoms at presentation
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Preoperative lab test revealed anemia in 19 patients,
leukocytosis in 15 patients and increasing levels of blood
urea nitrogen and creatinine in 13 cases. The mean
hemoglobin value before surgery was 11.5 ± 1.9 g/dL,
and the mean value of leukocytes was 10.6 ± 3.6 x
103/μL. One mechanism of anemia suggested by
Goodman and co. (16) would be a defect in the
reutilization of iron.
As shown in Table 2, the simultaneous presence of
anemia and leukocytosis was noticed in more than one
third of the patients, but also a high number of patients
did not present anemia nor leukocytosis.
A creatinine increase over 1.0 mg/dL (F) and over 1.2
mg/dL (M) was detected preoperatively in 13 patients
(44.82%). The mean level of creatinine was 1.03 ± 0.26
mg/dL, and the mean level of GFR was 63 ± 18
mL/min/1.73 m2. Kidney failure was noticed in 13
(44.82%) out of the 29 cases with a GFR < 60
mL/min/1.73 m2, but more than half of the patients

Figure 4. The distributions of the uropathogens
identified in urine cultures
In the following column chart – Figure 5, the strong
relationship between renal lithiasis and/or urinary tract
infections in association with Xanthogranulomatous
pyelonephritis is represented.

(55.17%) presented normal kidney function.
Table 2. Modifications of the complete blood count
Modifications

no

%

Anemia &
Leukocytosis

11

37.93

Only Anemia

8

27.59

Only
Leukocytosis

4

13.79

Neither
Anemia nor
Leukocytosis

6

20.69

The urine culture was positive in 18 patients (62.06%)
and negative in over one third of them (37.84%). In 16
out of the 18 cases with positive urine culture, a Gramnegative microorganism from the Enterobacteriaceae
family
was
detected,
while
Gram-positive
microorganisms were detected in only two cases (6.89%).
Our findings are consistent with those reported by a study
conducted in Greece (17), in terms of the urine culture
results.
As shown in the following column chart – Figure 4,
the most frequent microorganism identified was E. Coli,
followed by Proteus, Klebiella, Enterococcus and
Staphylococcus, while a significant number of patients
had sterile urine.
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Figure 5. The association of urinary tract
infections (UTI) and renal lithiasis in the study
group
Our study limitations reside in the retrospective
observational nature, the lack of standardized protocol,
the progression of the chronic renal disease after the
surgical treatment that could not been demonstrated and
the low number of cases presented in the study in
accordance with the disease prevalence.
It is generally accepted that XGP is caused by a
combination of diseases which includes obstructive
lithiasis and chronical infections (5). Persistent stasis
yields recurrent infections with subsequent coagulative
necrosis and destruction of the renal parenchyma. In our
study, renal lithiasis was found in 21 cases (72.41%),
which is a strong argument to support the etiopathogenic
theory, but we also enrolled 2 patients in which no urinary
tract infection or renal calculi were found.
The inflammatory process affects the whole kidney,
the focal forms being extremely seldom discovered (1820). Owing to its heterogeneous appearance, XGP can
easily be confused with renal cell carcinoma and/or
infiltrating urothelial carcinoma of the renal pelvis. There
are no findings to support the idea of a bilateral disease,
and no predilection for one side only, the percentages

Xanthogranulomatous pyelonephritis
being almost equal for both left or right sides (7). In this
study, we had 16 cases of xantogranulomatous
pyelonephritis located on the right side (55.17%), but the

but it revealed the presence of the XGP simultaneous with
renal carcinoma in six cases (20.68%).

number of cases and the low percentage cannot support
the predominance of this side.
The treatment for XGP is surgical, including open or
laparoscopic nephrectomy. Because of the clinical and
paraclinical exam, preoperative care should be
considered, and it often includes antibiotics and renal
drainage (by means of nephrostomy or JJ stent), in
combination or separately (21). The authors of a study
describe renal drainage using nephrostomy in 77.8% of
the overall 30 cases (2).
The preoperative treatment consisted only in
antibiotics in 13 cases (44,82%), while in more than a half
of the cases (55.17%) it was followed by drainage: 13
patients (44.82%) with percutaneous nephrostomy and 3
patients (10.34%) with JJ stent.
Regarding the surgical approach, open nephrectomy
was performed in 21 cases (72.41%), similar to the report
of a study which analyzed nephrectomy in inflammatory
renal disease in Brazil (22). Laparoscopic nephrectomy
was performed in 7 cases (24.13%) and partial
nephrectomy was the treatment of choice in only one case
(3.44%).
The laparoscopic treatment was frequently disputed,

Figure 6. The macroscopic evaluation of the
post-nephrectomy specimen

Conclusions
Our study succeeded in evaluating the demographic,
clinical,
paraclinical,
surgical and
histological
characteristics of this series of patients. Moreover, the
results of the study were compared with the data from
other studies. Xanthogranulomatous pyelonephritis affects

but some studies describe that a good experience in
laparoscopy can make this kind of intervention possible
also in xantogranulomatous pyelonephritis (23).
Laparoscopic nephrectomy for XGP is complicated and
more technically demanding than the laparoscopic
nephrectomy for noninfectious etiologies (24). For the
novice laparoscopist, however, the open approach should

mostly women (a W:M ratio up to 6:1) aged between 40
and 70 years.

remain the approach of choice.

(nephrectomy) in most cases, associated with antibiotic
therapy. Antibiotics alone cannot control the disease, but
associated with surgical therapy, they can prevent preand postoperative complications.
The diagnosis of certainty is mandatory to be
pathological, which is useful not only in the confirmation
of the disease, but also in the evaluation of its coexistence

Postoperative blood tests revealed anemia in 25 cases
(86.2%), leukocytosis in 12 cases (41.37 %) and the
presence of kidney failure (eGFR <60 mL/min/1.73 m2)
in 13 patients (44.82%).
The examination of the excisional specimen (postnephrectomy)
revealed
the
presence
of

The main symptoms are flank pain and fever,
occasionally patients can be asymptomatic. Blood
laboratory tests reveal mainly anemia, leukocytosis and
kidney failure. The most frequent microorganism found in
urine was E. Coli. The treatment was surgical

Xanthogranulomatous pyelonephritis, with characteristic
chronic inflammatory infiltration and lipid-laden
macrophages in all 29 cases – Figure 6. This is in

with renal carcinoma.

conformity with the results of the research conducted by
Arvind and co. (25, 26). The pathological examination
revealed the presence of XGP in only 23 cases (79.31%),
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publication of this article. The manuscript was read and
approved by all authors.
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